Improving patient quality of life by leveraging our unique albumin-based products and technologies.

NEWS & EVENTS

ALBUMEDIX ANNOUNCES EVALUATION AGREEMENT WITH A TOP PHARMA COLLABORATOR

COLLABORATION WILL EXPLORE ALBUMEDIX' VELTIS® TECHNOLOGY FOR IMPROVED FORMULATION AND DELIVERY OF MULTIPLE DRUG CANDIDATES

Read more
#CelebratingAlbumin no. IV

#CelebratingAlbumin Did you know that the shape of albumin is actually a heart? A more beautiful protein structure is difficult to come by and was initially discovered back in 1992, based on one of Albumedix’ recombinant human albumins. In this week’s story, we have dug out some of the original articles and look into the importance these early discoveries in albumin structure had on todays impact of albumin in patient health.

Read more
New Cancer Target Identified for Albumin Enabled Anti-Cancer Therapeutics

PRESS RELEASE: Aarhus, Denmark, and Nottingham, UK, June 26th, 2018 – Aarhus University's Interdisciplinary Nanoscience Center (iNANO) and Albumedix Ltd. (‘Albumedix’) have entered into a strategic research collaboration to evaluate the transport properties of albumin for site-selective drug delivery into disease cells to ensure more efficient and safer treatment for patients.

Read more
#CelebratingAlbumin no. III

#CelebratingAlbumin In this week’s story, the third in the series, we will be diving into the difference between #Albumin and #Albumen – words that only differs in an “i” or “e” but with a huge difference in meaning. Albumen referring to all water-soluble proteins and albumin – a specific protein found in blood plasma. Though undoubtedly a lot of interesting albumen proteins exist, it is this specific and wonderful protein – albumin - that we have spent the last 30 years exploring and will continue to in the pursuit towards Better Health.

Read more
#CelebratingAlbumin no. II

#CelebratingAlbumin To kick-off the celebration of albumin we will be taking you on a walk down memory lane by sharing some interesting facts and stories about albumin and its origin. Did you for example know that the history of albumin dates all the way back to the year 400 – discoveries and information still used to this day! We celebrate albumin because of its rich history and vast possibilities and in today’s story we bring focus on some of the historical albumin pioneers like #Hippocrates and #Paracelsus. In Albumedix we aspire to continue this pioneering spirit within the field of albumin, with the hope of creating Better Health for patients.

Read more
#CelebratingAlbumin no. I

#CelebratingAlbumin The most abundant human protein with an amazing history, yet often overlooked. Obviously, we are talking about albumin – a protein that has already played a key role in achieving Better Health for patients and still manages to amaze with its wealth of unique properties. Clearly, it deserves a celebration! At Albumedix we have made albumin the cornerstone of our company and the way by which our dedication towards Better Health is achieved. Over the coming months, we will share some of the rich history and remarkable benefits that albumin provides as we strive to increase our understanding even more in order to unravel its full potential. Follow us on our continuing journey towards understanding albumin better and its ability to create Better Health for patients.

Read more
Albumedix to host webinar on albumin in cell therapy

How recombinant human albumin can increase cell viability and provide consistent performance

Read more
Albumedix Establishes Scientific Advisory Board

Albumedix has announced the formation of a Scientific Advisory Board (SAB) to provide governance, oversight and advice to Albumedix’ R&D organization as it builds and develops its pipeline of proprietary and differentiated drugs

Read more
Albumedix joins UCL's Future Targeted Healthcare Manufacturing Hub

Albumedix joins University College London’s (UCL’s) Future Targeted Healthcare Manufacturing Hub along with a number of other industrial partners and academic institutions

Read more
Albumedix, Oslo University Hospital and University of Oslo establish strategic research collaboration

Albumedix has announced that it has signed a strategic research agreement with Oslo University Hospital and University of Oslo.

Read more

Albumin

Naturally designed to carry out multiple vital functions in the human body, albumin’s unique properties offer unlimited potential in the field of medical science. After 30 years exploring albumin biology we still strive to learn more.

Learn more

Products

Going beyond standard formulation strategies. Our Recombumin® portfolio of recombinant human albumin products, enables the effective formulation of otherwise hard-to-stabilize drug, vaccine and cell therapies.

Show me

Technology

Albumedix’ proprietary Veltis® technology platform offer new ways of enhancing therapeutic performance of active pharmaceutical agents by optimizing drug dosing, delivery and effect.

Read more

Pipeline

Albumedix has established a strong portfolio of valued partnerships. Our products and technologies are leveraged by partners across multiple indications and range from early-stage to marketed therapeutics.

Check it out

Dedicated to Better Health